Oragenics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NYSE American: OGEN
Share price (8/4/26): $0.55
Market cap (8/4/26): $2.482 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 128 pages Asset Purchase Agreement by and Among Oragenics Corporation and Odyssey Health, Inc. F/K/a Odyssey Group International, Inc. and Joseph Michael Redmond and Christine Farrell October 4, 2023

from 8-K 33 pages Asset Purchase Agreement by and Among Probiora Health, LLC, a Delaware Limited Liability Company (“Buyer”), Christine L. Koski, the Sole Member and Manager of Buyer and a Personal Guarantor (“Koski”), and Oragenics, Inc., a Florida Corporation (“Seller”) Effective as of June 22, 2016

from 8-K 14 pages Article 1 Definitions and Particular Terms